Recently, several studies suggested that radiofrequency (RF) ablation of the genicular nerves is a safe and effective therapeutic procedure for intractable pain associated with chronic knee osteoarthritis (OA). Diagnostic genicular nerve block (GNB) with local anesthetic has been generally conducted before making decisions regarding RF ablation. Although GNB has been recently performed together with corticosteroid, the analgesic effects of corticosteroids for treating chronic pain remain controversial.
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Methods

Patients
This randomized, double-blinded study was conducted from April to December 2012 at the Asan Medical Center in Seoul, Korea. Our study protocol was registered at Clinical Research Information Service (KCT 0001139) and was approved by our institutional review board (2012-0210), and written informed consent was obtained from all patients. We ascertained the eligibility of patients aged 50-80 years who presented with knee pain. Following clinical and radiological assessments, we enrolled a cohort of elderly patients with chronic knee pain (i.e., knee pain of moderate or greater intensity on most or all days for ≥ 3 months) and radiological tibiofemoral OA (Kellgren-Lawrence grade 2-4 as evaluated by a radiologist, Table 1 ) (16) .
The study exclusion criteria included acute knee pain, prior knee surgery, other connective tissue diseases that affected the knee, serious neurological or psychiatric disorders, steroid or hyaluronic acid injection therapy during the previous 3 months, sciatic pain, anticoagulant medication use, pacemaker use, and prior electroacupuncture treatment.
Interventional Procedures
No pre-medications or sedatives were administered. Each patient was placed in the supine position with a pillow under the popliteal fossa to alleviate discomfort. The examined area was prepared and draped according to standard sterile techniques, and the 12 MHz linear transducer (XarioTM SSA-660A, Toshiba Medical Systems Corporation, Otawara, Japan) was covered with sterile plastic. The transducer was first placed parallel to the long bone shaft and moved up or down to identify the epicondyle of the long bone. The genicular arteries were identified near the periosteal areas, which are the junctions of the epicondyle and the shafts of the femur and tibia, and confirmed by color Doppler ultrasound ( Fig. 1A-1C) . Accordingly, GNB target points should be next to each genicular artery because the superior lateral, superior medial, and inferior medial genicular C hronic knee osteoarthritis (OA) tends to affect elderly people and is characterized by severe pain, joint stiffness, and disability (1) . Patients with chronic knee OA are offered various conservative treatments, including oral analgesics, viscosupplementation, intraarticular corticosteroid injections, acupuncture, and prolotherapy. Despite these treatments, many patients continue to suffer from refractory knee pain (2) . Total knee joint arthroplasty may be a successful surgical option for cases that fail to respond to conservative treatments. However, surgery is associated with increased morbidity and mortality among patients with chronic knee OA, and its use is limited in high-risk patient with comorbidities (3).
Radiofrequency (RF) ablation of the genicular nerves, a recently introduced option, appears to be safe and effective for treating intractable knee OA pain, according to several studies (4) (5) (6) . Generally, a diagnostic genicular nerve block (GNB) with local anesthetic is performed before RF genicular ablation, and a successful response to GNB is considered to indicate the need for RF genicular ablation. However, one study suggested that GNB, when administered together with corticosteroid, is as effective as RF genicular ablation (7) . Despite this and other reports in which adjuvant corticosteroid therapy could contribute to and prolong the analgesic effect of the local anesthetic (8) (9) (10) , the analgesic effect of corticosteroids on a peripheral nerve block remains controversial.
Several studies have reported the successful performance of GNB or RF genicular ablation under ultrasound guidance. This technique is based on anatomical studies demonstrating that genicular nerves are accompanied by genicular arteries or are located near the adductor tubercle and medial collateral ligament (4, 11, 12) . Ultrasound-guided RF genicular ablation yielded both significant reductions in knee pain and improvements in functional capacity (13) (14) (15) .
Therefore, in the present study, we aim to evaluate the efficacy of a local anesthetic plus a corticosteroid versus a local anesthetic alone during ultrasoundguided GNB. After using color Doppler to confirm the genicular artery, the needle was inserted in the plane of the ultrasound probe in the long-axis view. After confirming the placement of the needle-tip next to a genicular artery, a gentle aspiration was performed and a 2 mL injection volume was administered. This method was used to inject a total of 6 mL of lidocaine or 6 mL of lidocaine plus 20 mg of triamcinolone (TA) at 3 separate target sites: the superior lateral, superior medial, and inferior medial genicular nerves (Table 2) .
After the procedure, all of the patients were advised to continue using any previously prescribed medications when their symptoms were persisted, whereas, they were advised to stop or reduce current medication when their symptoms were alleviated. The patients were prohibited any additional medications or physiotherapy regimens at the 8-week postprocedure period.
Outcome Measurements and FollowUp
An independent physician, who was blinded to the treatment allocations, performed all preoperative baseline and postprocedural outcome measurements (1, 2, 4, and 8 weeks) at the outpatient pain clinic. Baseline characteristics were recorded for all patients. Weight-bearing radiographs were reviewed at baseline, and the Kellgren-Lawrence system was used to grade the degree of OA. Outcome measures were assessed according to hospital visits at baseline and at 1, 2, 4, and 8 weeks after the procedure (Table 3) . Before each procedure, the patients were instructed in the use of a 100 mm visual analog scale (VAS) (range: no pain to unbearable pain) and Oxford Knee Score (OKS, Table 3 ), and baseline values were obtained. OKSs were based on self-administered, joint-specific 12-item questionnaires. Each question was scored from 1 to 5, with one representing either the best outcome and/or the fewest symptoms. The scores from each question were summed to yield overall scores ranging from 12-60, with 12 representing the optimal outcome (17) . At 1, 2, 4, and 8 weeks after the procedure, each
Fig. 1. Ultrasound-guided identification of GNB target sites. Representative longitudinal images of the knee at the level of the distal femoral condyle and medial tibial metaphysis are shown. The superior lateral (A), superior medial (B), and inferior medial (C) genicular nerves (arrowhead) accompany each genicular artery (white arrow).
patient completed a written questionnaire that requested an estimation of these measurements. Additionally, these questionnaires assessed global perceived effects on a 7-point scale (1 = worst ever, 2 = much worse, 3 = worse, 4 = not improved but not worse, 5 = improved, 6 = much improved, and 7 = best ever). To quantify changes in analgesics, the Medication Quantification Scale (MQS) was also measured (18) . Pain data were expressed as absolute values.
Primary outcomes included the mean changes from baseline levels of knee pain to 1, 2, 4, and 8 weeks after GNB, as www.painphysicianjournal.com Values are presented as means ± standard deviations. No significant intergroup differences were observed in any other variables. OKS = Oxford Knee Score; TA = triamcinolone; VAS = visual analog scale All data values are shown as means ± standard deviations. OKS = Oxford Knee Score; TA = triamcinolone; VAS = visual analog scale; GPES = global perceived effect *P < 0.05 compared with baseline values. measured using the VAS. Secondary outcomes included functional changes in the knee, patient satisfaction with treatment, changes in analgesics, the incidence of adverse effects, and the proportion of successful responders. We defined the successful responder, according to prior study, as the patient with a reduction of at least 50% of median VAS score and no increase from baseline OKS and MQS (19) . Patients were asked
The Effect of Ultrasound-Guided Genicular Nerve Block with Adjuvant Corticosteroid Table 4 . Questionnaires of OKS. www.painphysicianjournal.com to report any adverse effects to their physician at each visit or by telephone at any other time and were given additional advice and management. All adverse effects (e.g., numbness, paresthesia, neuralgia, and motor weakness) were recorded.
Statistical Analysis
Sample size calculations were based on the primary outcome of differences in the mean VAS score at 4 weeks after the procedure. A power analysis based on a pilot study indicated that a minimum of 22 patients per group would be needed to detect a difference with a mean VAS value of 20 (assuming a standard deviation [SD] of 23) with a study power of 0.8 and a 2-sided significance level of P < 0.05. Ultimately, a cohort of 48 patients was enrolled to accommodate an attrition rate of 10%.
All scale variables were tested for normality using the Kolmogorov-Smirnov test. For multiple comparisons, 2-way repeated measurements analyses of variance and Tukey's test were used to compare differences in VAS pain scores and OKS from baseline to 1, 2, 4, and 8 weeks after the procedure Unpaired t-tests were used to evaluate parametric data, and Mann-Whitney U tests were used for non-parametric data. Fisher's exact test was used for all categorical comparisons. The data analysis was performed using SPSS Version 11.0 (SPSS Inc., Chicago, IL). Values were estimated as means ± standard deviations. A threshold of P < 0.05 was used to denote a significant difference.
Randomization and Double-Blinding
A computer-generated randomization schedule was used to assign patients randomly to receive either the lidocaine alone (n = 24) or lidocaine plus TA (n = 24) during ultrasound-guided GNB. A single investigator was not involved in selection of patients or subsequent patient care. The patients also were blinded to the treatment type throughout the study. All of the procedures were performed by a single operator who was not blinded to the type of administered treatment.
Results
Study Population
As shown in Fig. 2, 38 of the 86 patients with knee pain who were screened for this study failed to meet the inclusion criteria. The excluded patients included 23 who refused to participate, 8 who had radiculopathy, 4 who had a history of steroid or hyaluronic acid injections within the previous 3 months, and 3 with a history of knee surgery. Ultimately, 48 patients met our study selection criteria and were randomized into 2 treatment groups. All patients completed the study, and the data from each patient were analyzed. GNB was successfully conducted in each patient, and no case involved a failure to find the genicular arteries under ultrasound guidance. There were no significant differences between the study groups regarding age, gender, height, weight, disease duration, nerve block site, baseline VAS score, baseline OKS, or baseline radiographic disease severity according to the Kellgren-Lawrence grade (Table 1) .
Primary Outcome
We detected a significant interaction between the treatment group and time to mean changes in VAS scores, as shown in Fig. 3 (P < 0.001). In the lidocaine plus TA group, VAS scores at 1, 2, and 4 weeks after the procedure were significantly lower than the baseline score (P < 0.001 for all). In the lidocaine group, VAS scores at 1 and 2 weeks were also significantly lower than the baseline score (P < 0.001 for both). When the groups were compared, the lidocaine plus TA group exhibited improved pain alleviation at both 2 and 4 weeks versus the baseline, compared to the lidocaine group (Table 2, P < 0.001 for both). The VAS scores in both groups returned to the baseline at 8 weeks.
Secondary Outcomes
In both groups, the postprocedural mean OKS exhibited changes relative to the baseline similar to those observed in VAS scores ( Table 2 ). The mean OKS decreased more significantly in the lidocaine plus TA group, compared to the lidocaine alone group, at 4 weeks after the procedure (P < 0.001). However, OKS of both groups returned to baseline levels at 8 weeks. Notably, at 4 weeks after the procedure, patient satisfaction was better in the lidocaine plus TA group (global perceived effect, 4.7 ± 0.7), compared with the lidocaine alone group (3.6 ± 0.6; P < 0.001). The changes in analgesics through the follow-up period are shown in Table 5 . Quantificational changes in analgesics (MQS) in both groups at 2 weeks after the procedure were considerably lower than baseline MQS. There was no difference in MQS between the 2 groups during the follow-up period. There were significantly more successful responders in the lidocaine plus TA group, compared with the lidocaine alone group at 2 weeks (P < 0.001, odd ratio 3.80, 95% confidence interval [1.696-8 .512] vs. odd ratio 0.26, 95% confidence interval [0.117-0.589]) (Fig. 4) . 
Adverse Events
During the procedures, most of the patients did not experience any discomfort or severe pain. No patient www.painphysicianjournal.com required additional medication or reported any postprocedural adverse events during the follow-up period.
discussion
When performing GNB under ultrasound guidance, we used the genicular arteries as landmarks. The superior lateral, superior medial, and inferior medial genicular arteries were easily identified by color Doppler at the junctions of the epiphysis with the shafts of the femur and tibia. Some studies have shown that genicular nerves were visible alongside the genicular arteries on ultrasound scans (13, 14) . In this study, we Celebrex 200 mg and Mobic 7.5 mg were prescribed as nonsteroidal anti-inflammatory drugs, first line analgesics. Tramadol/acetaminophen 362 mg and codeine/acetaminophen/ibuprofen one tablet were prescribed as weak opioid, second line. Fentanyl patch 12~25 mcg were prescribed as strong opioid, third line. All medications are commonly prescribed in Korea. MQS = indicated Medication Quantification Scale, which is a methodology of quantifying different drug regimens. *P < 0.05 compared with pre-procedure MQS.
verified that those nerves were distinguishable using the same ultrasound method (Fig. 1) . However, the genicular nerves might frequently be unidentifiable via ultrasound. As the genicular nerves mostly traveled along the arteries, the GNB targets should be placed next to each genicular artery, regardless of genicular nerve visualization. Accordingly, the present study demonstrated that GNB could be successfully performed under ultrasound guidance, thus corroborating other ultrasound-based studies (15, 20) . Although the addition of TA to lidocaine during GNB appeared to yield superior relief of knee pain up to 4 weeks after the procedure compared to GNB with lidocaine alone, clinically significant knee pain relief was only sustained for 2 weeks after reassessing VAS scores according to the concept of a minimal clinically important improvement for the intermediate base score tertile in a prior study (change in VAS scores > 27.4 mm) (21) . The addition of TA to lidocaine also seemed to yield significantly greater decreases in OKSs after 4 weeks, compared with the lidocaine alone. However, after reassessing the OKSs according to the minimal important changes, with reference to a prior study (change in OKS > 9 points) (22) , the clinical improvements in functional capacity only persisted for one week in both groups. Moreover, there were significantly more successful responders and MQS was considerably lower in the lidocaine plus TA group compared to the lidocaine alone group at only 2 weeks after the procedure. Therefore, the addition of corticosteroid therapy to ultrasoundguided GNB under a local anesthetic might not provide significant benefits when compared to GNB with a local anesthetic alone.
The decision to administer corticosteroid during a peripheral nerve block for pain control is important because corticosteroids may induce local or systemic adverse effects such as alopecia, cutaneous atrophy, cortisol suppression, glucose intolerance, and decreased bone mineral density (23) (24) (25) . However, the use of corticosteroids to enhance the effects of a peripheral nerve block remains controversial. Labat et al (26) reported that corticosteroid did not provide any benefits during a pudendal nerve block for pudendal neuralgia, and a recent study noted that the addition of dexamethasone as an adjuvant to local anesthetics did not appear to offer any benefits during scalp nerve blocks (27) . Furthermore, the addition of TA to local anesthetics was not associated with improved outcomes among patients who underwent a greater occipital nerve block to treat a transformed migraine (28) . By contrast, Afridi and colleagues (29) reported that corticosteroid injection into the greater occipital nerve yielded either complete response (pain-free, 22%) that lasted for a mean of 20 days or a partial response (> 30% reduction of pain, 31%) that lasted for a mean of 45 days among patients exhibiting primary headache syndromes. These authors suggested that the effects of the injection were indirect and acted via alterations in nociceptive processing and neuroplastic brain pathway mechanisms. In several systematic reviews and meta-analyses, dexamethasone, when used as an adjuvant to local anesthetics during peripheral nerve blocks for the upper and lower extremities, provided a better quality of postoperative analgesia and lower pain scores (30) (31) (32) . During GNB, the addition of a corticosteroid yielded functional improvements and reductions in knee pain for up to 6 months in patients with persistent knee pain after total knee replacement arthroplasty (TKRA), similar to the effects of genicular nerve radiofrequency (7) . However, the total administered TA dose in that study was 3 times higher than that used in the present study. Therefore, the effect of a GNB with corticosteroid might be a systemic effect in nature (10, 33) . Furthermore, the patients in the earlier study had undergone TKRA, and the persistent postprocedural pain might have been neuropathic or of an unknown etiology. Accordingly, it was not reasonable to insist that the addition of TA to lidocaine during GNB would yield a long-term analgesic effect in a patient with chronic knee OA. Most studies supporting the use of a corticosteroid as an adjuvant during peripheral nerve blocks conducted the procedures during the perioperative period and demonstrated only the short-term alleviation of acute postoperative pain (30) (31) (32) . Therefore, the use of corticosteroid as an adjuvant during peripheral nerve blocks for chronic pain was not previously found to be beneficial. Perineural corticosteroid administration should be evaluated further through well-designed studies.
This study had several limitations that warrant consideration. First, we did not evaluate the postprocedural plasma cortisol concentrations. An injection of steroids into an epidural space can suppress the pituitary axis system in a dose-dependent manner (34) . Although we used a single 20 mg dose of TA, cortisol depression might still have occurred in some patients. Additionally, the optimal steroid type or dose is unknown, and a different dose or type might have yielded different results. Therefore, our preliminary data should be validated in future large-scale studies. Second, we did not include www.painphysicianjournal.com a sham placebo group in our protocol and could not precisely evaluate the effects of lidocaine alone or in combination with TA during GNB. Third, we did not assess the emotional state of the patients in this study, although this factor might affect the perception of knee pain. Nevertheless, none of our patients changed their medications or physical therapy regimens. Although our cohort might have included patients with a minor depressive disorder, these patients would have only minimally affected our findings. Finally, our patients were followed-up for 2 months. Recent studies have generally followed patients for 3 months to evaluate the short-term effects. However, the 2-month outcomes in both groups did not differ from the baseline values. Therefore, a longer follow-up period might not have affected the present study's results.
Consequently, the addition of a corticosteroid during GNB for chronic knee pain could prolong the analgesic effect and improve the functional capacity over the short term. However, the clinical benefit of this addition was not significant when compared with the benefit from local anesthesia alone. Given the potential adverse effects of corticosteroids, the addition of these agents to local anesthetics might not be warranted during GNB for chronic knee OA.
